Taking Novartis’ Fabhalta (iptacopan) as a monotherapy — meaning as a sole treatment — twice daily for almost one…
Articles by Margarida Maia, PhD
An enzyme called lactate dehydrogenase (LDH), which is a marker of red blood cell breakdown, may be used as a…
People with paroxysmal nocturnal hemoglobinuria (PNH) who had a prior blood clot-related event are more likely to have such…
Unusual colon lesions caused by ischemic colitis led to the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) in an 82-year-old…
Iptacopan, an experimental oral medication being developed by Novartis, increased hemoglobin to near-normal levels in people with paroxysmal…
An experimental therapy being developed by Omeros can nearly double the level of hemoglobin safely after three doses in…